Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Xenon Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +2 vs. Q4 2021
- Shares held
- 49.2M
- +1.48M (+3.1%) vs. Q4 2021
- Total value
- $1.50B
- +$10.8M (+0.7%) vs. Q4 2021
- New holders
- 18
- 49 more added
- Sold out
- 16
- 40 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XENE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 315 | $6.10B |
| Q1 2026 | 290 | $5.80B |
| Q4 2025 | 245 | $3.78B |
| Q3 2025 | 219 | $3.39B |
| Q2 2025 | 206 | $2.60B |
| Q1 2025 | 206 | $2.58B |
| Q4 2024 | 209 | $2.99B |
| Q3 2024 | 203 | $2.95B |
| Q2 2024 | 213 | $2.89B |
| Q1 2024 | 220 | $3.16B |
| Q4 2023 | 204 | $3.32B |
| Q3 2023 | 181 | $2.10B |
| Q2 2023 | 175 | $2.36B |
| Q1 2023 | 163 | $2.19B |
| Q4 2022 | 159 | $2.38B |
| Q3 2022 | 154 | $2.09B |
| Q2 2022 | 151 | $1.73B |
| Q1 2022 | 132 | $1.50B |
| Q4 2021 | 130 | $1.49B |
| Q3 2021 | 118 | $521.7M |
| Q2 2021 | 103 | $620.0M |
| Q1 2021 | 91 | $590.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Xenon Pharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DAFNA Capital Management LLC | 380,163 | $11.6M | 3.03% | −22,504−5.6% | Reduced |
| Eversept Partners, LP | 410,021 | $12.5M | 1.15% | +200,502+95.7% | Added |
| Kynam Capital Management, LP | 483,270 | $14.8M | 4.80% | −186,823−27.9% | Reduced |
| Bank of New York Mellon Corp | 579,208 | $17.7M | 0.00% | −212,317−26.8% | Reduced |
| Boxer Capital, LLC | 600,000 | $18.3M | 0.94% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 604,254 | $18.5M | 0.13% | +73,743+13.9% | Added |
| BlackRock Inc. | 614,957 | $18.8M | 0.00% | +47,385+8.3% | Added |
| Samlyn Capital, LLC | 630,729 | $19.3M | 0.29% | +109,089+20.9% | Added |
| Adage Capital Partners GP, L.L.C. | 650,000 | $19.9M | 0.04% | −15,000−2.3% | Reduced |
| OrbiMed Advisors LLC | 686,000 | $21.0M | 0.34% | +55,000+8.7% | Added |
| Suvretta Capital Management, LLC | 692,000 | $21.2M | 0.65% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 724,337 | $22.1M | 0.01% | +552,943+322.6% | Added |
| Baker Bros. Advisors LP | 751,639 | $23.0M | 0.13% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 842,498 | $25.8M | 0.65% | +71,131+9.2% | Added |
| Capital International Investors | 868,297 | $26.5M | 0.01% | −187,429−17.8% | Reduced |
| Holocene Advisors, LP | 909,628 | $27.8M | 0.15% | +909,628 | New |
| Great Point Partners LLC | 920,000 | $28.1M | 6.81% | −30,000−3.2% | Reduced |
| Commodore Capital LP | 1,202,613 | $36.8M | 8.21% | +112,487+10.3% | Added |
| Pictet Asset Management SA | 1,325,326 | $40.5M | 0.05% | +1,325,326 | New |
| Morgan Stanley | 1,440,171 | $44.0M | 0.01% | +568,087+65.1% | Added |
| Citadel Advisors LLC | 1,441,080 | $44.1M | 0.05% | +153,277+11.9% | Added |
| Marshall Wace, LLP | 1,534,058 | $46.9M | 0.10% | +313,101+25.6% | Added |
| BVF Inc | 1,597,966 | $48.9M | 1.95% | −1,691,574−51.4% | Reduced |
| Lord, Abbett & Co. LLC | 1,790,743 | $54.7M | 0.15% | −4,337−0.2% | Reduced |
| Point72 Asset Management, L.P. | 2,146,450 | $65.6M | 0.29% | −846,147−28.3% | Reduced |
| Polar Capital Holdings Plc | 2,190,059 | $67.0M | 0.39% | +502,015+29.7% | Added |
| Capital World Investors | 2,274,974 | $69.5M | 0.01% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,411,447 | $73.7M | 1.53% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 3,300,427 | $100.9M | 1.24% | +177,198+5.7% | Added |
| FMR LLC | 3,833,476 | $117.2M | 0.01% | −76,541−2.0% | Reduced |
| Avoro Capital Advisors LLC | 4,985,000 | $152.4M | 2.78% | 00.0% | Unchanged |
| International Biotechnology Trust PLC | 25,500 | – | – | 00.0% | Unchanged |
| Altrinsic Global Advisors LLC | 0 | $0 | 0.00% | −170,000−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −59,702−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −47,920−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −36,279−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −25,043−100.0% | Sold out |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −24,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,304−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −12,911−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −12,215−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,014−100.0% | Sold out |
| Difesa Capital Management, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −7,266−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Turim 21 Investimentos Ltda. | 0 | $0 | 0.00% | −1,466−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −454−100.0% | Sold out |